ADCT

Latest SEC Filings & News for ADCT

2 most recent filings and news items mentioning ADCT. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/ADCT/news?limit=20"

Pull ADCT filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

RegulatoryJun 3, 2026Positive

ADC Therapeutics ZYNLONTA plus rituximab met primary endpoint in Phase 3 LOTIS-5 trial

ADC Therapeutics announced positive topline data from LOTIS-5 Phase 3 trial showing ZYNLONTA combined with rituximab achieved statistical significance on progression-free survival versus standard immunochemotherapy in relapsed/refractory DLBCL patients. The company plans to file

View filing at SEC.gov →

RegulatoryJun 2, 2026Neutral

ADC Therapeutics files Articles of Association for Swiss corporation

ADC Therapeutics SA updated its Articles of Association, establishing corporate governance structure with registered office in Epalinges, Switzerland. The filing documents standard organizational and operational provisions with no material changes to business operations or financ

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.